lung cancer

Ricardo Cubedo, MD
November 14, 2019 · Greg Guthrie, ASCO staff
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>
October 17, 2019 · Claire Smith, ASCO staff
In this podcast, Dr. Vamsidhar Velcheti discusses an early study on a new targeted therapy for non-small cell lung cancer. Read More >>
2019 ASCO ® Annual Meeting; #ASCO19
June 3, 2019 · Greg Guthrie, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer. Read More >>
2019 ASCO ® Annual Meeting; #ASCO19
June 1, 2019 · Monika Sharda, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer. Read More >>
January 3, 2019 · Narjust Duma, MD
The stigma of lung cancer has powerful consequences for those diagnosed with the disease. Dr. Narjust Duma shares the story of a patient who was brave in the face of lung cancer but feared the judgment of her community. Read More >>

Pages